Clinical Trials on Endometrial Safety in Australia
Total 94 results
-
Queensland Centre for Gynaecological CancerNational Health and Medical Research Council, Australia; Johnson & Johnson... and other collaboratorsCompletedEndometrial CancerUnited Kingdom, Australia, Hong Kong, New Zealand
-
Q32 Bio Inc.CompletedSafety IssuesAustralia
-
CerevanceCompleted
-
Nanjing Immunophage Biotech Co., LtdRecruiting
-
Island PharmaceuticalsBeyond Drug DevelopmentCompletedSafety and TolerabilityAustralia
-
Medical University of ViennaCompletedEndometrial Neoplasms | Cancer of Endometrium | Carcinoma of EndometriumAustria
-
Annexon, Inc.Nucleus Network LtdCompletedSafety and Tolerability in Healthy VolunteersAustralia
-
Annexon, Inc.TerminatedSafety and Tolerability in Healthy VolunteersAustralia
-
MingSight Pharmaceuticals Pty LimitedCompletedSafety and PK in Healthy VolunteersAustralia
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance)-Conditional ICDsAustralia, Germany, Switzerland, Austria, Singapore
-
Kepler University HospitalRISC Software GmbH; innovethic eU; FiveSquare GmbHActive, not recruiting
-
SignPath Pharma, Inc.Completed
-
Arch Biopartners Inc.CompletedNone - Study is to Determine Safety in Healthy ParticipantsAustralia
-
Affiris AGCompleted
-
Prof. Peter Gerner, M.D.CompletedEfficacy and Safety Study of Dexmedetomidine as an Additive to Local Anesthetics in Shoulder SurgerySelf Efficacy | Drug SafetyAustria
-
Menzies School of Health ResearchCharles Darwin University; Northern Territory of Australia as represented by... and other collaboratorsRecruitingAboriginal Health | Cultural Safety | Access to Interpreters | Healthcare Provider TrainingAustralia
-
Queensland Centre for Gynaecological CancerCompleted
-
Queensland Centre for Gynaecological CancerThe University of Queensland; Greenslopes Private Hospital; Sullivan and Nicolaides...Completed
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance) Conditional CRT-pacemakers and ICDsFrance, Germany, Hungary, Canada, Australia, Austria, Czech Republic, Switzerland
-
Biotronik AGCompletedLong Term Safety of the AMS 1.0Switzerland, Germany, Australia, Belgium, Netherlands
-
Krankenhaus Barmherzige Schwestern LinzCompletedEndometrial Cancer | Atypical HyperplasiaAustria
-
Queensland Centre for Gynaecological CancerGlaxoSmithKline Research & Development LimitedNot yet recruitingMmr Deficiency | Endometrial Cancer Stage I | Immune-related Adverse Event | Endometrioid Endometrial AdenocarcinomaAustralia
-
Queensland Centre for Gynaecological CancerThe University of Queensland; Queensland University of TechnologyActive, not recruitingComplex Endometrial Hyperplasia With Atypia | Grade 1 Endometrial Endometrioid AdenocarcinomaAustralia, New Zealand
-
Actinogen MedicalICON plcCompletedCognitive Function | Peripheral Neuropathy | Electrocardiography | Central Nervous System | Safety | Healthy Ageing | Cortisol | Cerebrospinal Fluid | Small Fibre NeuropathyAustralia
-
Queensland Centre for Gynaecological CancerRoyal Brisbane and Women's Hospital; Queensland Institute of Medical ResearchCompletedEndometrial CancerAustralia
-
GuerbetCompletedGeneral Safety Profile of DOTAREMArgentina, China, France, Spain, India, United Kingdom, Austria, Germany, Italy, Saudi Arabia
-
National Cancer Institute, NaplesRecruitingEndometrial CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Spain, United Kingdom
-
Medical University InnsbruckUnknown
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
BlueSky Immunotherapies GmbHEnrolling by invitation
-
Ruhr University of BochumCompletedCervical Cancer | Endometrial CancerAustria, Germany
-
Multitude Therapeutics Inc.Tigermed Consulting Co., LtdRecruitingOvarian Cancer | Ovarian Epithelial Cancer | Lung Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Ovarian Clear Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial... and other conditionsChina, Australia
-
Medical University of ViennaCompleted
-
Medical University of ViennaUnknownGlaucoma | Safety Issues | Efficacy, Self | Post-Op Complication | Glaucoma SurgeryAustria
-
Queensland Centre for Gynaecological CancerRoyal Brisbane and Women's Hospital; The University of Queensland; Queensland... and other collaboratorsCompletedCervical Cancer | Ovarian Cancer | Endometrial Cancer | Female Genital Diseases | Vulval CancerAustralia
-
Leiden University Medical CenterComprehensive Cancer Centre The Netherlands; Dutch Cancer SocietyActive, not recruitingEndometrial Cancer Stage I | Endometrial Cancer Stage IINetherlands, Germany, Belgium, France, Austria, Czechia, Ireland, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Endometrial CancerBelgium, France, Italy, Canada, Spain, Australia, Germany, United States, Japan, Brazil, Singapore, Russian Federation, Poland
-
European Organisation for Research and Treatment...CompletedEndometrial CancerBelgium, Austria, United Kingdom, Portugal, Italy, Spain
-
Canadian Cancer Trials GroupCanadian Cancer Clinical Trials NetworkRecruitingEndometrial CancerCanada, Australia, Netherlands
-
Medical University of GrazTerminatedLeiomyosarcoma | Endometrial Stromal Tumors | Carcinosarcomas UterineAustria
-
NCIC Clinical Trials GroupCompletedEndometrial CancerCanada, United States, Australia
-
Queensland Centre for Gynaecological CancerThe University of QueenslandRecruitingSurgery | Sentinel Lymph Node | Endometrial Cancer Stage IAustralia, United States, Brazil, Singapore, India
-
Medical University InnsbruckCompletedEmergencies | Pain, Acute | Trauma, Multiple | Safety | Analgesics | Accident | Field Physician Care | HypnoticsAustria
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Norway, Canada, Australia, Japan
-
Western Sydney Local Health DistrictBristol-Myers Squibb; University of Western SydneyRecruitingMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastric Cancer | Mesothelioma | Endometrial Cancer | Lung Cancer, Nonsmall CellAustralia
-
European Organisation for Research and Treatment...CompletedEndometrial CancerNetherlands, France, Spain, United Kingdom, Belgium, Italy, Austria, Portugal
-
Haihe Biopharma Co., Ltd.TerminatedBreast Cancer | Ovarian Cancer | Solid Tumor | Prostate Cancer | Endometrial CancerUnited States, Australia, China
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States, Canada, Norway, United Kingdom, Australia